ADIPOQ and Obesity: However, the presence of lower peripheral adiponectin levels could promote the development of dyslipidaemia through several deleterious mechanisms (obesity, chronic inflammation, insulin resistance, blood pressure deregulation, and changes in the lipid profile) [37].